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Abstract
Background: Abscess formation is a frequent local complication of leg erysipelas. In this study we aimed at identifying
factors associated with abscess formation of leg erysipelas in patients in sub-Saharan African countries.
Method: This is a multicenter prospective study conducted in dermatology units in eight sub-Saharan African countries
from October 2013 to September 2014. We performed univariate and multivariate analysis to compare characteristics
among the group of patients with leg erysipelas complicated with abscess against those without this complication.
Results: In this study, 562 cases of leg erysipelas were recruited in the eight sub-Saharan African countries. The mean
age of patients was 43.67 years (SD =16.8) (Range: 15 to 88 years) with a sex-ratio (M/F) of 5/1. Out of the 562 cases, 63
patients (11.2 %) had abscess formation as a complication. In multivariate analysis showed that the main associated
factors with this complication were: nicotine addiction (aOR = 3.7; 95 % CI = [1.3 – 10.7]) and delayed antibiotic treatment
initiation (delay of 10 days or more) (aOR = 4.6; 95 % CI = [1.8 – 11.8]).
Conclusion: Delayed antibiotics treatment and nicotine addiction are the main risk factors associated with abscess
formation of leg erysipelas in these countries. However, chronic alcohol intake, which is currently found in Europe as
a potential risk factor, was less frequent in our study.
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Background
Cellulitis is an infection of the deep layers of the skin
(dermis and hypodermis), mainly caused by streptococ-
cus species [1]. Its localization on the face has become
rare meanwhile; the lower limbs localization is currently
more frequent. There are various risk factors associated
with lower extremities cellulitis such as; lymphoedema,
site of entry, leg oedema, venous insufficiency, traumatic
wound, leg ulcers, toe-web intertrigo, excoriated leg
dermatosis [2, 3]. Various complications might occur
during the course of cellulitis. The local and general
complications frequently reported are abscess, superficial
necrosis or deep venous thrombosis, these complications
might occur as from the first days, but relapse of cellu-
litis and its sequelae occur sometimes later [4]. Abscess
formation is the most frequent local complication [4, 5],
furthermore, a study conducted in Europe showed that
risk factors identified to be associated with abscess for-
mation were chronic alcohol intake, as well as, delayed
antibiotic treatment initiation [6]. In Africa, very few
data on the risk factors for abscess formation in celluli-
tis’s patients have been published. In this multicenter
study, we aim at identifying risk factors associated with
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abscess formation among patients presenting with cellu-
litis of lower extremities in sub-Saharan African countries.
Method
Type and population of the study
This is a multicenter prospective study conducted in
dermatology units of eight sub-Saharan African coun-
tries. There were six countries from West Africa (Togo,
Senegal, Mali, Côte d’Ivoire, Guinea, and Burkina Faso)
and two central African countries (Central African
Republic and Cameroon). We recruited patients more
than 15 years old who attended dermatology consultation
for the onset of leg’s cellulitis. The study period was twelve
months from October, 2013 to September, 2014.
Data collection
A validated questionnaire from two study centers was
used to collect data. The variables collected from each
patient were:
i) Sociodemographic and anamnesis’ data i.e. age, sex,
use of non-steroid anti-inflammatory drugs and use of
cataplasm before consultation. ii) Clinical data i.e. the
site of cellulitis, the degree of pain, the occurrence of
fever and/or shivering, cutaneous signs: phlyctenas, and
purpura, satellite adenopathy, and skin complications
such as abscess formation and necrosis.
During the consultation, patients were asked for the
date of onset of cellulitis (debut of at least one of the
four following signs and symptoms: pain, redness, swell-
ing of the leg and warm leg) and the date of antibiotic
initiation if antibiotic was started before consultation. In
general most of patients have started antibiotics the day
of the consultation, but few patients had already started
antibiotics before the consultation. A patient was consid-
ered to have a delay in antibiotic initiation when the
period between the onset of cellulitis and antibiotic initi-
ation exceeded 10 days. Patients were followed up dur-
ing hospitalization to record outcome information.
During patient’s hospitalization, the onset of an abscess
was diagnosed by a physician. Once diagnosed, the
abscess was incised and drained.
Other variables were also collected from patients
through history taking, as well as trough clinical and
biological examinations, they were: iii) In medical his-
tory, we searched for chronic alcohol intake, seden-
tary life style and nicotine addiction: iv) In clinical
examination, we looked for point of entry (traumatic
wound, vascular ulcers, excoriations, intertrigo of
intertie), pitting edema, varicous veins, arteriopathy,
previous surgery of the leg, deep venous thrombosis,
obesity (BMI ≥30), hypertension, neurologic disorders
and/or use of bleaching products; v) in Lab test we
performed: Glucose and HIV tests.
Statistical analysis
Data were recorded using Epi Info software version 3.1
and analyzed in SPSS® 20.0 (IBM Corporation, Armonk
NY, USA) software. For continuous variables, means and
standard deviations were calculated while for categorical
variables we calculated proportions. Our primary outcome
of interest was patients who had complication of cellulitis
with abscess formation compare to those without abscess
formation. Chi square or Fisher exact test were used when
appropriate in univariate analysis. Multivariate backwards
stepwise logistic regression analysis was performed to iden-
tify independent risk factors for the dichotomous outcome
complication of cellulitis with abscess formation or absence
of abscess. All variables significant during univariate
analysis at a p-value less than 0.2 were then included in the
multivariate analysis to assess the adjusted effect and derive
the adjusted odds ratio (aOR) of each on the primary
outcome. We allocated the value “1” to the dependent
dichotomous variable if cellulitis becomes complicated
with abscess formation, and the value 0 otherwise. A 95 %
level of confidence was applied throughout.
Ethical issues
Ethics clearance was obtain from each Ethics Committee
board of the Universities of the 8 countries participating
in this study. The participant signed an informed con-
sent form, after the verbal explanation was delivered by
the investigating officers. The survey was anonymous
and confidential.
Results
From October, 2013 to September, 2014, a total of 562
cases of leg’s cellulitis were recruited in the eight partici-
pating countries. The mean age of patients was 43.7 years
(SD = 16.8) ranging from15 to 88 years. The sex-ratio
(M/F) was 5/1. Out of 562 cases, 63 (11.2 %) had abscess
formation as complication. Chronic alcohol intake was
found in 2/63 patients (3.2 %), while nicotine addiction
was found in 7/63 patients (11.1 %). Meanwhile, 1/63
(1.6 %) patient was infected with HIV. Concerning the
point of entry, 12/63 (19 %) had inter-toes intertrigo
and 43/63 (68.3 %) had neglected wounds on the legs
(Table 1). Delayed antibiotic treatment was found in
492/562 patients (87.5 %) (Table 1).
In univariate analysis, associated factors of abscess
formation in patient with cellulitis of the leg were:
nicotine addiction (OR = 2.71; 95 % CI = [1.1 – 6.6]), the
use of bleaching agents (OR = 0.4; 95 % CI = [0.2 – 0.9]),
delayed antibiotics treatment initiation (delay of 10 days
or more): OR = 5.2; 95 % CI = [2.2 – 12.1]); the use of
non steroid anti-inflammatory drugs before consultation
(OR = 2.4; 95 % CI = [1.4 – 4.1]); the use of cataplasms
and decoctions before consultation (OR = 2.5; 95 %
CI = [1.4 – 4.5]) (Table 1).
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Table 1 Risk factors associated with abscess formation of leg erysipelas, univariate analysis
Characteristics Total Abscess formation OR 95 % CI P
N = 562 (%) Yes, n (%) No, n (%)
Age
<25 years 76 (13.5) 10 (13.2) 66 (86.8) 1 - 0.43
25-35 years 134 (23.9) 11 (8.2) 123 (91.8) 0.59 [0.24 – 1.46]
>35 years 352 (62.6) 42 (11.9) 310 (88.1) 0.89 [0.43 – 1.86]
Gender
Male 223 (39.7) 31 (13.9) 192 (86.1) 1.55 [0.92 – 2.62] 0.10
Female 339 (60.3) 32 (9.4) 307 (90.4) 1
Obesity
Yes 230 (40.9) 23(10.0) 200 (90.0) 0.81 [0.47 – 1.40] 0.45
No 332 (59.1) 40(12.0) 292 (88.0) 1
Chronic alcohol intake
Yes 18 (3.2) 2 (11.1) 16 (88.9) 0.99 [0.22 – 4.41] 0.67
No 544 (96.8) 61 (11.2) 483 (88.8) 1
Diabetes
Yes 27 (4.8) 2 (7.4) 25 (92.6) 0.62 [0.14 – 2.69] 0.76
No 535 (95.2) 61 (11.4) 474 (88.6) 1
Hypertension
Yes 81 (14.4) 10 (12.3) 71 (87.7) 1.14 [0.55 – 2.34] 0.73
No 481 (85.6) 53 (11.0) 428 (89.0) 1
Sedentary
Yes 85 (15.1) 12 (14.1) 73 (85.9) 1.37 [0.70 – 2.70] 0.36
No 477 (84.9) 51 (10.7) 426 (89.3) 1
Nicotine addiction
Yes 29 (5.2) 7 (24.1) 22 (75.9) 2.71 [1.11 – 6.63] 0.03
No 533 (84.8) 56 (10.5) 477 (89.5) 1
HIV infection
Yes 16 (2.8) 1 (6.2) 15 (93.8) 0.52 [0.07 – 4.01] 0.44
No 546 (97.2) 62 (11.4) 484 (88.6) 1
Pitting oedema
Yes 130 (23.1) 20 (15.4) 110 (84.6) 1.65 [0.93 – 2.91] 0.08
No 432 (76.9) 43 (10.0) 389 (90.0) 1
Varicous vein
Yes 19 (3.4) 2 (10.5) 17 (89.5) 0.93 [0.21 – 4.21] 0.64
No 543 (96.6) 61 (11.2) 482 (88.8) 1
Obstructive arteriopathy
Yes 5 (0.9) 1 (20.0) 4 (80.0) 1.99 [0.22 – 18.14] 0.45
No 557 (99.1) 62 (11.1) 495 (88.9) 1
Use of bleaching agents
Yes 97 (17.3) 5 (5.2) 92 (94.8) 0.38 [0.15 – 0.98] 0.04
No 465 (82.3) 58 (12.5) 407 (87.5) 1
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Furthermore, on multivariate analysis, associated risk
factors with abscess formation that remained statisti-
cally significant were nicotine addiction (aOR = 3.7; 95 %
CI = [1.3 - 10.7]) and delayed antibiotics treatment ini-
tiation (delay of 10 days or more: aOR = 4.6; 95 %
CI = [1.8 - 11.8]) (Table 2).
Discussion
This was a multicenter prospective study carried out
in dermatology units in eight sub-Saharan African
countries, aiming at identifying risk factors associated with
abscess formation as complication of lower extremities
cellulitis. Nicotine addiction and delayed in antibiotic
treatment initiation were identified as the risk factors
associated with abscess formation of leg cellulitis in
these countries. Meanwhile, biological analysis of this
skin infection was not performed.
Abscess formation is the most frequent complication
of cellulitis. In our study we found 11.2 % of this
complication. A meta-analysis of this skin disease
conducted within a period of 20 years showed that
abscess formation, necrosis and/or deep venous
thrombosis complicated 3 % to 12 % of lower limb
cellulitis [4]. Krasagakis et al [5] found (46/145)
31.7 % of cases of leg cellulitis to be complicated with
abscess formation, while others authors, Picard et al. [6],
Mahe et al. [7], Crickx et al. [8] observed 7.9 %, 9.9 % and
3.6 % of cases, respectively. Meanwhile, a monocenter
study conducted in Lomé (Togo) detected only (3/67)
4.5 % cases of this complication [9].
Abscess formation is the most frequent, and the main
cause of morbidity in lower extremities cellulitis, which
prolonged patient’s hospitalization and increased the
financial coast for both patient and the community.
Table 1 Risk factors associated with abscess formation of leg erysipelas, univariate analysis (Continued)
Previous history of phlebitis
Yes 2 (0.4) 0 (0.0) 2 (100.0) - - 0.79
No 560 (99.6) 63 (11.2) 497 (88.8)
Previous history of surgery of the leg
Yes 6 (1.1)) 2 (33.3) 4 (66.7) 4.06 [0.73 – 22.62] 0.14
No 556 (98.9) 61 (11.0) 495 (89.0) 1
Neurologic disorders
Yes 1 (0.2)) 0 (0.0) 1 (100.0) - - 0.88
No 561 (99.8) 63 (11.2) 498 (88.8)
Intertrigo of intertoe
Yes 161 (28.6) 12 (7.5) 149 (92.5) 0.55 [0.29 – 1.07] 0.07
No 401 (71.4) 51 (12.7) 350 (87.3) 1
Neglected wound on the leg
Yes 324 (57.7) 43 (13.3) 281 (86.7) 1.67 [0.95 – 2.92] 0.07
No 238 (42.3) 20 (8.4) 218 (91.6) 1
Delayed of antibiotics treatment at onset of erysipelas
<3 days 104 (18.5) 8 (7.7) 96 (92.3) 1 - <0.001
3-10 days 295 (52.5) 23 (7.8) 272 (92.2) 1.01 [0.44 – 2.33]
>10 days 93 (16.5) 28 (30.1) 65 (69.9) 5.17 [2.22 – 12.05]
Use of non steroidanti inflammatory drugs
Yes 207 (36.5) 35 (16.9) 172 (83.1) 2.38 [1.40 – 4.04] 0.001
No 355 (63.5) 28 (7.9) 327 (92.1) 1
Use of cataplasms and decoctions before consultation
Yes 104 (18.5) 21 (20.2) 83 (79.8) 2.51 [1.41 – 4.45] 0.001
No 458 (81.5) 42 (9.2) 416 (90.8) 1
Table 2 Risk factors associated with abscess formation of
erysipelas of the leg, multivariate analysis
Characteristics aOR 95 % CI for aOR
Nicotine addiction
3.75 [1.32 ; 10.70]
Delayed antibiotics treatment
at onset of erysipelas
More than 10 days 4.65 [1.84 ; 11.80]
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In our study we identified two risk factors associ-
ated with abscess formation of leg cellulitis: delayed
antibiotics treatment initiation and nicotine addiction.
Delayed antibiotics treatment initiation increases the
risk of abscess formation by 1.4 to 4.6 as reported in many
other studies [5, 6, 8, 9], thereby, bacteria would become
more pathogenic, and invade the deep layers of the skin.
We could not give pathophysiological relation between
this complication and nicotine addiction. Nevertheless,
nicotine addiction could induced an immune depression
as in chronic alcoholism, which was not currently found
in our study compared to another publication [6].
Furthermore, obesity, diabetes, HIV infection and the
use of bleaching products, which are more frequent in
sub-Saharan Africa [5, 10], were not found as risk factors
associated with local complications and severe cellulitis
in this study.
Limitations
This study did not investigate biological aspects of skin
infection, which could explain the pathophysiological as-
pects of abscess formation among patients with leg cel-
lulitis. Also, socioeconomic condition of patients may
have influenced the delay in antibiotic initiation. Finally,
some recall bias could have occurred during recording
of anamnesis information. However, in the eight partici-
pating dermatology units, investigation officers have
used a validated structured data collection tool, in order
to, reduce information bias across countries.
Conclusion
In this study we found that abscess formation is a very
frequent complication of leg cellulitis, which is mainly
due to nicotine addiction and delayed antibiotics treat-
ment initiation. Knowing these risk factors may help
early detection and treatment of this complication.
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